| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Pneumocystis jirovecii by PCR (Lower Resp) BUMCT
MessageWD sites send to SQL, testing performed at BUMCT
Test Code
Alias/See Also
Preferred Specimen
Minimum Volume
Transport Temperature
Specimen Stability
Refrigerated: 7 days
Frozen: 2 weeks
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
3M MdX Liaison
Setup Schedule
Report Available
Clinical Significance
A real-time PCR assay for the in vitro qualitative detection of Pneumocystis jirovecii in bronchoalveolar lavage (BAL) and bronchial washing.
Qualitative Pneumocystis jirovecii PCR does not differentiate between colonization and acute infection. This result should be evaluated in conjunction with clinical signs and symptoms.
Limit of Detection: 79 copies/mL
Sensitivity of 97.1% and Specificity of 91.7%.
This test was developed, and its performance characteristics determined by Banner Health/Laboratory Sciences of Arizona. It has not been cleared or approved by the U.S. Food and drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary since the laboratory is approved under CLIA for high complexity testing.
